News
Waters and TetraScience Partner to Deliver New Levels of Data Access and Insights with Empower Data Science Link
Waters Corporation announced it has entered a reseller agreement with TetraScience, a cloud technology innovator powering transformational changes in life sciences R&D. Through the partnership, Waters will now offer its customers the Empower™ Data Science Link, powered by TetraScience....
News
Elsevier and LexisNexis Collaborate to Increase Access to Patent Information in Pharma and Chemical R&D Workflows
Elsevier, a global leader in research publishing and information analytics, announced a new collaboration with LexisNexis Legal & Professional to strengthen the existing patent coverage in Reaxys®, its information solution for chemistry R&D. This integration gives companies and researchers...
Drug Research
Insilicos Chemistry42 AI system integrated into UCBs drug discovery programs
Insilico Medicine, an AI drug discovery company, announced that UCB will integrate Insilico's Chemistry42™ into UCB's internal drug discovery pipeline. UCB's early adoption of Insilico Medicine's proprietary technology will provide UCB's scientists with the ability to design novel hit...
News
Poxel Announces Completion of Arbitration with Merck Serono
POXEL SA, a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), announced the completion of its arbitration1 with Merck Serono.
The arbitral tribunal dismissed the majority of Merck...
News
Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in UK and South Africa Trials
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced final efficacy of 96.4% against mild, moderate and severe disease caused by the original COVID-19 strain in a pivotal Phase 3 trial in the United Kingdom...
Drug Research
PsiVac and Lonza Enter a Strategic Agreement for the Process Development and cGMP Manufacturing of Ixovex-1
PsiVac, a subsidiary of Ixogen; a UK biotechnology research and development company focused on the development of new therapeutic cancer treatments for solid tumors, and Lonza, a world leader in contract manufacturing, announced their agreement for the process development...
News
Altimmune Expands AdCOVID Manufacturing Collaboration with Lonza
Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that it has expanded its previously-announced AdCOVID™ manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated manufacturing suite for clinical and commercial production of AdCOVID, Altimmune’s single-dose intranasal...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.